Latest Technology Platform News

EAU Lithium has committed to acquiring Vulcan's proven A-DLE Pilot Plant 4 from Germany, strengthening its capacity to optimise lithium extraction from Bolivian brines and supporting strategic deployment of VULSORB® technology.

Dotz Nano has secured A$3.3 million through a private placement, backing its next phase of production scale-up and customer engagement under incoming CEO Nati Harpaz.

Cobalt Blue Holdings and Glomar Minerals have shortlisted four US sites and begun testwork for Project Infinity, aiming to build the first commercial polymetallic nodule refinery in the United States.

Simble Solutions edges closer to $1 million in annual recurring revenue as major customer rollouts advance and its NanoSensor program moves forward along a structured development pathway.

Praemium plans a staged rollout of its new core technology platform this year, following the integration of Technotia Laboratories. The company has restructured its tech team to cut costs and revised incentive payments for two founding Technotia principals transitioning to consulting roles.

Simble Solutions is on the cusp of revealing initial results from its NanoSensor technology development, targeting major markets including Industrial IoT, defence sensing, and wearable medical devices.

Australian Finance Group (ASX:AFG) has kicked off a $15 million on-market share buyback, aiming to return capital to shareholders while maintaining strategic flexibility amid recent share price softness.

Norwood Systems has expanded its CogVoice project with an additional A$595,000 contract variation, reinforcing its role in a major Australian telco’s platform modernisation.

Janison Education Group has wrapped up its largest FY26 assessment programs including NAPLAN and its first New Zealand Ministry of Education event, while progressing AI capabilities and navigating a $3 million revenue impact from exiting NSW venue hire services.

Imagion Biosystems has secured FDA clearance to proceed with its Phase 1b/2 trial of the MagSense® HER2 Imaging Agent, targeting improved detection of HER2+ breast cancer. Patient recruitment is expected to start in Q3 2026, marking a crucial step toward commercialisation.

Stakk Ltd has secured a significant U.S. healthcare technology contract, pushing its annualised revenue run rate to approximately A$26 million. The deal highlights accelerating adoption of its AI-native Digital Trust platform across regulated industries.

Findi Limited surged revenue by 36% to $83 million for FY26 but posted a hefty $52.6 million net loss, weighed down by integration costs and capital delays. The company completed a major consolidation of its Indian financial infrastructure assets and secured $25 million in fresh capital to support growth and liquidity.